Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get your Portfolio automatically emailed to you up to 4 times a day with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Lensar Inc (LNSR)

Lensar Inc (LNSR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
LENSAR, Inc. CEO Nick Curtis to Participate in BTIG 4th Annual Ophthalmology Day Fireside Chat

LENSAR CEO Nick Curtis will speak at BTIG Ophthalmology Day, with 1-on-1 investor meetings.Quiver AI SummaryLENSAR, Inc., a medical technology company specializing in robotic laser solutions for cataract...

LNSR : 7.44 (+1.09%)
LENSAR to Participate in the BTIG 4th Annual Ophthalmology Day

LNSR : 7.44 (+1.09%)
LENSAR Reports Third Quarter 2024 Results and Provides Business Update

LNSR : 7.44 (+1.09%)
LENSAR Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

LNSR : 7.44 (+1.09%)
LENSAR to Report Third Quarter 2024 Financial Results on Thursday, November 7, 2024

LNSR : 7.44 (+1.09%)
One Millionth Procedure Completed Using LENSAR’s Cataract Laser Systems

LNSR : 7.44 (+1.09%)
LENSAR Reports Fourth Quarter and Full Year 2022 Results and Provides Business Update

LENSAR, Inc. (Nasdaq: LNSR) (“LENSAR” or “the Company”), a global medical technology company focused on advanced femtosecond laser surgical solutions for the treatment of cataracts, today announced...

LNSR : 7.44 (+1.09%)
LENSAR to Report Fourth Quarter and Full Year 2022 Financial Results on Thursday, March 16, 2023

LENSAR, Inc. (Nasdaq: LNSR) (“LENSAR” or “the Company”), a global medical technology company focused on advanced femtosecond laser surgical solutions for the treatment of cataracts, today announced...

LNSR : 7.44 (+1.09%)
LENSAR Announces Preliminary Fourth Quarter and Full Year 2022 Results

LENSAR, Inc. (Nasdaq: LNSR) (“LENSAR” or “the Company”), a global medical technology company focused on advanced femtosecond laser surgical solutions for the treatment of cataracts, today announced...

LNSR : 7.44 (+1.09%)
LENSAR to Present at Two Upcoming Investor Conferences

LENSAR, Inc. (NASDAQ: LNSR) (“LENSAR” or “the Company”), a global medical technology company focused on advanced femtosecond laser surgical solutions for the treatment of cataracts, today announced...

LNSR : 7.44 (+1.09%)

Barchart Exclusives

This Dividend Stock Yielding 5% Hasn't Made Money for Buffett, But Could It Work for You?
Kraft-Heinz has not made money for Warren Buffett for almost a decade, since the merged entity started trading. Should you bet on the stock for its 5% dividend yield? Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar